Arrowhead Pharmaceuticals (ARWR) Exchange Rate Effect (2021 - 2026)
Arrowhead Pharmaceuticals (ARWR) posted Exchange Rate Effect of $997000.0 for Q1 2026, up 840.57% on a QoQ basis from $106000.0 in Q4 2025, and up 348.01% year-over-year from $222539.7 in Q1 2025.
Arrowhead Pharmaceuticals (ARWR) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Arrowhead Pharmaceuticals' Exchange Rate Effect history runs 6 years deep, the most recent figure standing at $997000.0 for Q1 2026.
- Quarterly Exchange Rate Effect rose 348.01% year-over-year to $997000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (down 67.83% YoY) and the FY2025 annual result came in at -$401000.0, down 109.55% from the prior year.
- Exchange Rate Effect was $997000.0 for Q1 2026 at Arrowhead Pharmaceuticals, up from $106000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $4.3 million in Q3 2024 and bottomed at -$402000.0 in Q1 2025.
- A 5-year average of $279352.9 and a median of $1000.0 in 2022 frame the typical range for Exchange Rate Effect.
- Peak annual rise in Exchange Rate Effect reached 5000.0% in 2023, while the deepest fall reached 7500.0% in 2023.
- Arrowhead Pharmaceuticals' Exchange Rate Effect stood at -$122000.0 in 2022, then surged by 147.54% to $58000.0 in 2023, then plunged by 217.24% to -$68000.0 in 2024, then soared by 255.88% to $106000.0 in 2025, then surged by 840.57% to $997000.0 in 2026.
- Business Quant data shows ARWR's Exchange Rate Effect at $997000.0 in Q1 2026, $106000.0 in Q4 2025, and -$24000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Arrowhead Pharmaceuticals | 12.14 Bn | 10.36 Bn | - | 997,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 997,000.00 |
| Mar 31, 2026 | 997,000.00 |
| Dec 31, 2025 | 106,000.00 |
| Dec 31, 2025 | 106,000.00 |
| Sep 30, 2025 | -24,000.00 |
| Sep 30, 2025 | -24,000.00 |
| Jun 30, 2025 | 93,000.00 |
| Jun 30, 2025 | 93,000.00 |
| Mar 31, 2025 | -402,000.00 |
| Mar 31, 2025 | -402,000.00 |
| Dec 31, 2024 | -68,000.00 |
| Dec 31, 2024 | -68,000.00 |
| Sep 30, 2024 | 4.34 Mn |
| Sep 30, 2024 | 4.34 Mn |
| Jun 30, 2024 | -223,000.00 |
| Jun 30, 2024 | -223,000.00 |
| Mar 31, 2024 | 26,000.00 |
| Mar 31, 2024 | 26,000.00 |
| Dec 31, 2023 | 58,000.00 |
| Dec 31, 2023 | 58,000.00 |